Physician profile
Bahador Tafazoli
NPI 1811984149
$26,478.36
in general payments reported to CMS, 2019-2025
46 companies · $5,384 in 2025
The $5,384 reported for 2025 was more than what 93% of Sleep Medicine (Family Medicine) providers received nationally (typical 2025 total: $557).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $466 · 2020: $615 · 2021: $753 · 2022: $2,971 · 2023: $3,431 · 2024: $13K · 2025: $5,384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,240 · Travel and Lodging: $2,941 · Education: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,335.67 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,240.00 |
| Travel and Lodging | $2,941.36 |
| Education | $156.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $7,925.29 | 2019-2025 | Xywav |
| Inspire Medical Systems, INC. | $7,638.48 | 2022-2025 | Inspire |
| Harmony Biosciences LLC | $1,466.67 | 2020-2025 | Wakix |
| Axsome Therapeutics, INC. | $1,131.58 | 2023-2025 | Sunosi, Symbravo |
| Glaxosmithkline, LLC. | $874.49 | 2020-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Astrazeneca Pharmaceuticals Lp | $849.57 | 2019-2025 | Airsupra, Breztri, Tezspire |
| Regeneron Healthcare Solutions, INC. | $689.46 | 2024-2025 | Dupixent |
| Genzyme Corporation | $676.27 | 2024-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $643.08 | 2023-2025 | Lumryz |
| Grifols USA, LLC | $594.46 | 2020-2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $589.69 | 2019-2025 | Glassia, Cuvitru |
| Boehringer Ingelheim Pharmaceuticals, INC. | $492.06 | 2023-2025 | Ofev, Jascayd |
| Actelion Pharmaceuticals US, INC. | $232.08 | 2023-2025 | Uptravi, Opsumit |
| Abbvie INC. | $219.44 | 2021-2023 | Botox |
| Mylan Specialty L.P. | $196.36 | 2023-2024 | Yupelri |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharming Healthcare, INC. | $185.00 | 2023-2024 | Ruconest |
| Genentech USA, INC. | $176.53 | 2021-2025 | Xolair |
| Merck Sharp & Dohme LLC | $172.20 | 2019-2025 | Zerbaxa |
| Pulmonx Corporation | $156.82 | 2025 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Arbor Pharmaceuticals, INC. | $152.94 | 2019-2021 | |
| Viatris Specialty LLC | $141.46 | 2025 | Yupelri |
| United Therapeutics Corporation | $123.26 | 2023-2025 | Tyvaso, Tyvaso |
| Pfizer INC. | $110.33 | 2019-2022 | |
| Insmed, INC. | $105.97 | 2023-2024 | Arikayce |
| Philips North America LLC | $103.94 | 2024-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Amgen INC. | $103.57 | 2025 | Tezspire |
| Lilly USA, LLC | $93.43 | 2022-2025 | Zepbound |
| Ucb, INC. | $89.47 | 2021-2022 | |
| Amarin Pharma, INC. | $78.52 | 2019-2021 | |
| Baxter Healthcare | $60.83 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Ironshore Pharmaceuticals INC. | $57.12 | 2019 | |
| Allergan, INC. | $41.79 | 2019-2020 | |
| Novo Nordisk INC | $39.06 | 2019 | |
| Csl Behring | $34.80 | 2024 | Kcentra |
| 3b Medical, INC. | $29.89 | 2023-2025 | Luna |
| Inogen, INC. | $26.49 | 2023 | Inogen At Home Stationary Concentrator, Inogen One G5 Oxygen Concentrator - Bluetooth |
| Verona Pharma, INC. | $25.25 | 2025 | Ohtuvayre |
| Astellas Pharma US INC | $19.55 | 2024 | Cresemba |
| Melinta Therapeutics, LLC | $18.85 | 2023 | Vabomere |
| Corium, LLC | $17.53 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $17.27 | 2020 | |
| Eisai INC. | $16.47 | 2022 | |
| Janssen Pharmaceuticals, INC | $16.11 | 2020 | |
| Resmed Corp | $15.30 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.86 | 2020 | |
| Ironwood Pharmaceuticals, INC | $14.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bahador Tafazoli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.